Article

jdsupra.com on 2021-12-30 20:05

No Clear Error to Find Lack of Written Description for a Method of Treatment Patent Despite Separate Disclosures of the Drug, Disease, and Dose (as Part of a Range)

Biogen International GMBH, Biogen MA, Inc., v. Mylan Pharmaceuticals Inc. marks the Federal Circuit’s most recent interpretation of the 35 U.S.C. § ...

Related news

Can Enablement and Written Description Bars be Lower for Method-Of-Treatment Patent Claims?jdsupra.com
Method of Treatment Claims Are Not Invalid for Lacking Written Description or Enablement Simply Because the Treatment Is Not Safe or Efficacious in Some Patients jdsupra.com
Supreme Court Denies Review of the Written Description Requirement jdsupra.com
Lower Austria
District Court: Prosecution History Context Defeats Written Description Requirement jdsupra.com
West Virginia
Inherent Disclosure Satisfied Written Description jdsupra.com
Germany , District of Columbia
Rehearing Denied in Federal Circuit’s Ruling Against Tecfidera® Patent for Lack of Written Description jdsupra.com
Outlier? Split Federal Circuit Denies En Banc Review of Written Description Requirement jdsupra.com
Federal Circuit Finds Adequate Written Description Support Under the Doctrine of Inherent Disclosure jdsupra.com
Visual Memory v. NVIDIA: The Importance of a Robust Written Description jdsupra.com
Federal Circuit analyzes requirement for written description of negative claim limitations jdsupra.com
Statement of Invention or “Hunting Expedition”?: Written Description for Claimed Ranges jdsupra.com
IPR on Written Description? Claims Found Unpatentable Based on Lack of Entitlement to Priority Date jdsupra.com
Lack of Written-Description Support for Claimed Ranges Makes Parent Application Prior Art jdsupra.com
Federal Circuit: 2D Depiction of 3D Article Can Satisfy Written Description in a Design Patent jdsupra.com
California , United States , Switzerland
The Federal Circuit Explains Admissibility of Post-Priority Date Evidence Regarding Written Description and Enablement Proofs jdsupra.com
Federal Circuit Imposes Heightened Standard for Written Description Support of Negative Claim Limitations jdsupra.com
Another Genus Claim Bites the Dust for Lack of Written Description jdsupra.com
Written Description: What Is the Proper “Dosage” to Satisfy This Requirement?jdsupra.com
West Virginia
Genus Claims: Foiled again by Written Description jdsupra.com
Heightened Written Description Standard for Negative Limitations?jdsupra.com